SF
Seamus Fernandez Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
34
Avg Return
Past Year
Past Year
41%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
97.1%
Neutral
2.9%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
---|---|---|---|---|---|---|---|---|
Buy
Maintained
| $948 |
14%
upside
| 5 | +3.9% |
0
%
| 8 Oct ‘25 4 days ago |
|
|
Buy
Maintained
| $167 |
48%
upside
| 5 | +59% |
0
%
| 25 Sep ‘25 17 days ago |
|
|
Buy
Maintained
| $84 |
463%
upside
| 2 | +94% |
0
%
| 23 Sep ‘25 19 days ago |
|
|
Buy
Maintained
| $25 |
75%
upside
| 2 | +77% |
0
%
| 15 Sep ‘25 27 days ago |
|
|
Buy
Maintained
| $14 |
88%
upside
| 2 | +51% |
0
%
| 14 Aug ‘25 1 month ago |
|
|
Buy
Maintained
| $90 |
199%
upside
| 1 | +84% |
0
%
| 7 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $120 |
19%
upside
| 2 | +44% |
0
%
| 6 Aug ‘25 2 months ago |
|
|
Buy
Reiterated
| $116 |
121%
upside
| 5 | +4.4% |
0
%
| 2 Jul ‘25 3 months ago |
|
|
Buy
Reiterated
| – | – | 3 | +20% |
0
%
| 3 Apr ‘25 6 months ago |
|
|
Buy
Reiterated
| – | – | 1 | +92% |
0
%
| 25 Mar ‘25 6 months ago |
|
|
Buy
Reiterated
| $160 |
266%
upside
| 2 | -25% |
0
%
| 12 Mar ‘25 7 months ago |
|
|
Buy
Initiated
| $56 |
6%
upside
| 1 | +77% |
0
%
| 25 Feb ‘25 7 months ago |
|
|
Buy
Reiterated
| – | – | 1 | +341% |
0
%
| 24 Feb ‘25 7 months ago |
|
|
Buy
Maintained
| $122 |
42%
upside
| 2 | -7.8% |
0
%
| 17 Jan ‘25 8 months ago |
|
|
Neutral
Downgraded
| – | – | 1 | – |
–
| 31 Oct ‘24 11 months ago |
|